Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy
- PMID: 32888447
- DOI: 10.1016/S1470-2045(20)30424-1
Drug repurposing for cancer treatments: a well-intentioned, but misguided strategy
Comment in
-
Drug repurposing in oncology.Lancet Oncol. 2020 Dec;21(12):e542. doi: 10.1016/S1470-2045(20)30561-1. Lancet Oncol. 2020. PMID: 33271099 No abstract available.
-
Drug repurposing in oncology.Lancet Oncol. 2020 Dec;21(12):e543. doi: 10.1016/S1470-2045(20)30610-0. Lancet Oncol. 2020. PMID: 33271100 No abstract available.
-
Drug repurposing in oncology - Authors' reply.Lancet Oncol. 2020 Dec;21(12):e544. doi: 10.1016/S1470-2045(20)30692-6. Lancet Oncol. 2020. PMID: 33271101 No abstract available.

